Welcome to the Medela University

Own mother’s milk is a low cost intervention as high dose and long exposure reduces the incidence of chronic infant co-morbidities. However, the breastfeeding journey may be, particularly in high-risk populations such as mothers with a sick or preterm infant. In this webinar, you will learn which best practices have proven to be efficient to initiate lactation, build long-term milk production and increase the dose of mother’s own milk NICU infants. Moreover, you will learn more about how to personalise pasteurised Donor Human Milk with strategies to restore and modulate the intestinal microbiota in this vulnerable group of infants. This program has been approved for 1.4 contact hours; provider approved by the California Board of Registered Nursing, CEP 13692.   Presenters Dr. Daniela Much Daniela Much, PhD, IBCLC is Scientific Manager at Medela Europe since 2018. Before joining Medela, she was study coordinator and researcher at Technical University Munich and Helmholtz Center Munich, with over 10 years of experience in clinical trials in breastfeeding and lactating women and their infants. Her areas of research interest include the importance of effective lactation initiation in high-risk populations and proactive management of lactation care of mothers with preterm infants using a quality improvement approach. Dr. Much has published her work in several peer-reviewed journals and is speaker at national and international conferences.   Prof. Rosalina Barroso Rosalina Barroso, MD is Head of the Neonatal Intensive Care Unit at Prof. Doutor Fernando Fonseca Hospital in Portugal. With over 20 years of clinical experience in neonatology, she was President of the Neonatal Portuguese Society from 2013 until 2016. Her areas ofresearch interest include nutrition and infection and the link between these two. Dr. Barroso has received the “Prémio da Qualidade Maria Amélia de Mello” and the "Prémio Bial de Medicina Clínica" awards for her work in neonatology.   Dr. Chiara Tabasso Dr. Chiara Tabasso is a Nutritional Biologist working since many years in the Donor Human Milk Bank “Nutrici” and Nutrition Center Mangiagalli, IRCCS Ospedale Maggiore Policlinico Milan, in Italy. She is personally involved in analysis of donor human milk, donors' screening and several research activities focused on donor human milk and human milk, such as the inoculation and personalization of donor human milk. Dr. Tabasso has applied her expertise in biology to nutritional science, so her research activities also cover nutritional assessments and studies about body composition of mothers and their children. Read more

This presentation highlights the newest evidence that mothers’ own milk is “personalized medicine” for NICU infants, and summarizes why donor human milk feedings do not yield the same beneficial outcomes.  Given that there is no optimal substitute for mothers’ own milk, strategies to prioritize its availability in the NICU are essential.  This session targets the first two weeks post-birth as a critical period that includes secretory activation and achievement of coming to volume in breast pump-dependent mothers of NICU infants, and includes evidence, best practices and the newest ongoing research in this area. This program has been approved for 1.0 contact hours; provider approved by the California Board of Registered Nursing, CEP 13692. This course is CPD (Continuing Professional Development) certified.    Presenter Prof. Paula Meier, PhD, RN Paula Meier, PhD, RN, is a Professor of Pediatrics and Nursing at Rush University Medical Center in Chicago. Dr. Meier has worked as a practitioner, researcher, and educator in the area of human milk, lactation and breastfeeding for premature infants and their mothers since 1975. Dr. Meier's lifetime research focus has been on the improvement of initiation and maintenance of lactation in breast pump-dependent mothers of NICU infants, and in the development and testing of clinical techniques to optimize the impact of human milk on health and cost outcomes in NICU infants. Read more

Übersicht Warum ist die orale Therapie mit Kolostrum/eigener Muttermilch wichtig? Wichtige Inhaltsstoffe Kolostrum / Muttermilch Immunfaktoren, Stammzellen und HAMLET Wann und wie erfolgt die orale Therapie   Referentinnen Manuela Burkhardt Hebamme, Lehrerin für Hebammenwesen, Heilpraktikerin, Still- und Laktationsberaterin IBCLC, Fortbildungsbeauftragte bei Medela   Nicole Rohnert Kinderkrankenschwester, Still- und Laktationsberaterin IBCLC, Heilpraktikerin, Fortbildungsbeauftragte bei Medela Read more

In this talk, Professor Geddes will discuss her research which uses the latest technology to investigate breastfeeding patterns, explore why some women feel pain during breastfeeding, and as well, understand how our vulnerable preterm babies feed at the breast. She will discuss what to expect when breastfeeding, ways to overcome pain experienced during breastfeeding by some women, and will outline how milk changes in response to the mums and the baby’s health to protect them both. With this knowledge we can reassure or advise breastfeeding mums with more confidence along their breastfeeding journey. This webinar is hosted by UWA and Medela AG as part of the UWA Research Impact Series. This program has been approved for 1.0 contact hours; provider approved by the California Board of Registered Nursing, CEP 13692.   Presenter Professor Donna Geddes (AUS) Professor, School of Molecular Sciences @The University of Western Australia Professor Geddes is internationally renowned for her novel work with ultrasound imaging that has revolutionized the our understanding of the anatomy of the lactating breast, milk ejection and blood flow, as well as the infant’s sucking technique, suck-swallow-breathe co-ordination, gastric emptying and body composition of both the term and preterm infant. She has since expanded her range of research interests to include the synthesis and removal of milk from the breast, the composition of human milk and its impact on the growth and body composition of breastfed infants, the investigation of HM metabolites and the search for biomarkers that are indicative of breast dysfunction. Read more

In this course, we will learn more about the direct and indirect impact of COVID-19 on NICU families and explore strategies to provide family-centered care to support families during COVID-19 and beyond.       This program has been approved for 1.0 contact hours; provider approved by the California Board of Registered Nursing, CEP 13692.   Presenter Kelli D. Kelley Kelli D. Kelley is the Founder and CEO of Hand to Hold, a US non-profit organization dedicated to providing education and support for Neonatal Intensive Care Unit and bereaved families. A NICU graduate parent who suffered from psychosocial issues for years after her children’s early births, she now invests her time and talents to raise awareness about the high incidence of anxiety, depression and post-traumatic stress disorder among these parents and the long-term implications for the baby and family. Kelli serves as Vice President of board of directors of the US National Coalition for Infant Health. Read more

In this course, Dr. Powell will describe the human milk immune system, focusing on the antibody response after infection or vaccination, and the functions of those antibodies for infants, or as a potential therapeutic for all. Specifically, you will learn about current research on the human milk antibody response to SARS-CoV-2 infection, and very recent data on the milk antibody response following vaccination against COVID-19. This program has been approved for 1.0 contact hours; provider approved by the California Board of Registered Nursing, CEP 13692.   Presenter Assistant Professor Rebecca Powell, PhD CLC Dr Rebecca Powell is an Assistant Professor of Medicine and Infectious Diseases at Mount Sinai's Icahn School of Medicine. She studies the immune properties of human milk. Dr. Powell currently has several active projects aimed to fill knowledge gaps about human milk immunology, exploring: the antibody response to SARS-CoV-2 infection and vaccination; the antibody response to influenza vaccine; and the design of maternal vaccines to eliminate mother-to-child-transmission of HIV via breastfeeding. Read more